Mylan Inc (MYL.OQ)
|Market Cap (Mil.):||$16,026.39|
|Shares Outstanding (Mil.):||382.86|
NEW DELHI, Nov 26 - Biocon Ltd said on Tuesday it has won the Indian drug regulator's approval for marketing a generic version of Roche's Herceptin breast cancer treatment.
Note: Reuters has not verified this story and does not vouch for its accuracy.
Nov 18 - Mylan Inc : * Launches first generic Focalin XR capsules, 30 mg * Says awarded 180 days marketing exclusivity * Says dexmethylphenidate hydrochloride extended-release capsules, 30 mg, is the first generic version of novartis' focalin xr * Source text for Eikon * Further company coverage
* Says took remedial action on US FDA warning on Agila unit plant
Sept 27 - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:
(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49sfor the Morning News Call newsletter http://link.reuters.com/nex49s) U.S. stock index futures fell on Friday as deadlines loomed for a political agreement in Washington that would keep the U.S. government running and avoid a debt default, with no clear solution in sight. S&P 500 futures fell 8 points, Dow Jones industrial average futures fell 48 points, and Nasdaq 100 fu
WASHINGTON - Generic drugmaker Mylan Inc has won U.S. antitrust approval to buy Agila, a unit of India's Strides Arcolab Ltd , subject to divesting some products, the Federal Trade Commission said on Thursday.
WASHINGTON, Sept 26 - Generic drugmaker Mylan Inc has won U.S. antitrust approval to buy Agila, a unit of India's Strides Arcolab Ltd, subject to divesting some products, the Federal Trade Commission said on Thursday.
WASHINGTON, Sept 26 - Generic drugmaker Mylan Inc has won U.S. antitrust approval, with conditions, to buy Agila, a unit of India's Strides Arcolab Ltd, the Federal Trade Commission said on Thursday.
NEW DELHI, Sept 3 - India's cabinet on Tuesday approved Mylan Inc's deal to buy a unit of Strides Arcolab Ltd, Information and Broadcasting Minister Manish Tewari said, paving the way for closure of the long-pending transaction.
|Dr. Reddy's Laboratories Limited (REDY.NS)||Rs2,400.50||-2.90|
|Johnson & Johnson (JNJ.N)||$91.23||+0.07|
|Pfizer Inc. (PFE.N)||$30.21||-0.04|
|Novartis AG (NOVN.VX)||CHF68.30||-0.05|
|Merck & Co., Inc. (MRK.N)||$48.45||+0.13|
|Roche Holding Ltd. (ROG.VX)||CHF234.40||-1.80|
|Abbott Laboratories (ABT.N)||$36.46||+0.17|
|Bayer AG (BAYGn.DE)||€95.43||-0.26|
|Bayer AG (BAYE.F)||--||--|
|GlaxoSmithKline plc (GSK.L)||1,570.50p||0.00|
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Trading Report for (MYL). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Wright Reports
Provider: ValuEngine, Inc.